How many drugs treat Enterobacter Cystitis?

Drug Landscape tracks 3 marketed treatments for Enterobacter Cystitis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/enterobacter-cystitis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Enterobacter Cystitis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enterobacter Cystitis (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Enterobacter Cystitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Furacin	NITROFURAZONE	Takeda	nitrofurazone	Sterile alpha and TIR motif-containing protein 1	1945-01-01
MACRODANTIN	NITROFURANTOIN, MACROCRYSTALLINE	ALMATICA	Nitrofuran Antibacterial [EPC]	Mitochondrial pyruvate carrier 2, CDGSH iron-sulfur domain-containing protein 1, Glucose-6-phosphate 1-dehydrogenase
Ofloxacine	Ofloxacine	Assistance Publique - Hôpitaux de Paris		Gamma-aminobutyric acid receptor subunit alpha-2, Histamine H3 receptor, Muscarinic acetylcholine receptor M1

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 3 drugs in Enterobacter Cystitis
ALMATICA · 1 drug in Enterobacter Cystitis
Assistance Publique - Hôpitaux de Paris · 1 drug in Enterobacter Cystitis
Takeda · 1 drug in Enterobacter Cystitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Enterobacter Cystitis:

Cite this brief

Drug Landscape (2026). Enterobacter Cystitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/enterobacter-cystitis. Accessed 2026-06-10.

Enterobacter Cystitis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing